Monday, May 20, 2013

Protected: pSivida gets nod in European approval process of Iluvien

February 28, 2012 by stephenkilmer · Leave a Comment

Filed under Briefs · Tagged with Alimera Sciences, ASX:PVA, chronic DME, DCP, Decentralized Procedure, diabetic macular edema, DME, fluocinolone acetonide, Iluvien, intravitreal insert, Medicines and Healthcare products Regulatory Agency of the United Kingdom, MHRA, NASDAQ, NASDAQ:PSDV, Paul Ashton, posterior, PSDV, pSivida, Reference Member State, RMS, sustained-release, uveitis

This post is password protected. Enter the password to view comments.